| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/26/2011 | CA2481325C Anti-hiv composition, production method thereof and medicament |
| 07/26/2011 | CA2441225C A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 07/26/2011 | CA2411249C Gasc1 gene |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2352467C Apoptosis-inducing factor |
| 07/26/2011 | CA2299677C Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 07/26/2011 | CA2289912C Human receptor proteins; related reagents and methods |
| 07/26/2011 | CA2222757C Modified/chimeric superantigens and their use |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/21/2011 | WO2011088127A1 Wnt-binding agents and uses thereof |
| 07/21/2011 | WO2011088120A1 Antibody formulation and therapeutic regimens |
| 07/21/2011 | WO2011088047A1 Soluble endoglin and uses thereof |
| 07/21/2011 | WO2011087364A1 Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof |
| 07/21/2011 | WO2011087092A1 Anti-influenza antibody and influenza detection device |
| 07/21/2011 | WO2011087091A1 Anti-asct2 (system asc amino acid transporter type 2) antibody |
| 07/21/2011 | WO2011086973A1 Antibody specific to activated egfr |
| 07/21/2011 | WO2011086179A1 Methods for diagnosis and treatment of cutaneous t cell lymphomas |
| 07/21/2011 | WO2011086143A2 Liver targeting molecules |
| 07/21/2011 | WO2011086141A1 Bacterial host strain expressing recombinant dsbc |
| 07/21/2011 | WO2011086138A1 Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene |
| 07/21/2011 | WO2011086091A1 Multivalent antibodies |
| 07/21/2011 | WO2011086001A1 Antibodies for the treatment of hcv |
| 07/21/2011 | WO2011085574A1 Complete human anti-tnf-alpha monoclonal antibodies, and manufacturing methods and uses thereof |
| 07/21/2011 | WO2011064664A3 T cell receptors specific for immunodominant ctl epitopes of hcv |
| 07/21/2011 | WO2011008517A3 Immunoglobulin fc polypeptides |
| 07/21/2011 | US20110179505 Rodent cancer model for human fgfr4 arg388 polymorphism |
| 07/21/2011 | US20110179501 Methods for Reverting Methylation by Targeting DNMT3A and DNMT3B |
| 07/21/2011 | US20110178279 Development of masked therapeutic antibodies to limit off-target effects: application to anti-egfr antibodies |
| 07/21/2011 | US20110178278 Antibody Against the CSF-1R |
| 07/21/2011 | US20110178277 Stabilized single domain antibodies |
| 07/21/2011 | US20110178276 Surface neutralization of apatite |
| 07/21/2011 | US20110178270 T-cell death-inducing epitopes |
| 07/21/2011 | US20110178269 Coronavirus S Peptides |
| 07/21/2011 | US20110178004 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 07/21/2011 | US20110177998 Bioactive peptides and methods of using same |
| 07/21/2011 | US20110177977 Antibodies for detecting or monitoring a malignant plasma cell disease |
| 07/21/2011 | US20110177614 Compositions and methods for detecting cancer |
| 07/21/2011 | US20110177589 Novel human polyomavirus |
| 07/21/2011 | US20110177556 Nucleic Acids Encoding Chimeric CD154 Polypeptides |
| 07/21/2011 | US20110177536 Novel antibodies recognizing native annexin a3 |
| 07/21/2011 | US20110177528 Methods for detecting and inhibiting angiogenesis |
| 07/21/2011 | US20110177526 Janus family kinases and identification of immune modulators |
| 07/21/2011 | US20110177525 Antibodies and methods of diagnosing diseases |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/21/2011 | US20110177112 Multi- component l2 vaccine for prevention of human papilloma virus infection |
| 07/21/2011 | US20110177096 Use of gpr151 modulators for the treatment of pain |
| 07/21/2011 | US20110177095 Anti-her2 antibodies and their uses |
| 07/21/2011 | US20110177090 Glycan markers and autoantibody signatures in HIV-1 and HIV-1-associated malignancies |
| 07/21/2011 | US20110177088 Method for Treating and Diagnosing Hematologic Malignancies |
| 07/21/2011 | US20110177087 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 07/21/2011 | US20110177085 Bitter Taste Receptors |
| 07/21/2011 | US20110177083 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 07/21/2011 | US20110177082 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/21/2011 | US20110177081 Pharmaceutical compositions of antibodies for diseases caused by viruses |
| 07/21/2011 | US20110177080 Novel p2x7 epitopes |
| 07/21/2011 | US20110177078 Immunogen and Antivenom Against Violin Spider Venom |
| 07/21/2011 | US20110177077 Pax 5 monoclonal antibody |
| 07/21/2011 | US20110177076 Humanized anti-amyloid beta antibodies |
| 07/21/2011 | US20110177074 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 07/21/2011 | US20110177073 Recombinant production of mixtures of antibodies |
| 07/21/2011 | US20110177070 TGF-Beta Antagonist Multi-Target Binding Proteins |
| 07/21/2011 | US20110177068 Pharmaceutical preparation comprising an antibody against the egf receptor |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177065 Methods of treating/preventing inflammation using combination of il-1 antagonist and il-18 binding protein |
| 07/21/2011 | US20110177057 Pharmaceutical preparation and manufacturing method thereof |
| 07/21/2011 | US20110177022 Mammalian Cytokines; Related Reagents and Methods |
| 07/21/2011 | US20110177007 Dithienopyrrole Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177006 Dithienofuran Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177002 Cylic polyamines for binding phosphatidylserine |
| 07/21/2011 | US20110176996 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
| 07/21/2011 | US20110176995 Diagnosis and treatment of cancer using anti-gpr49 antibody |
| 07/21/2011 | CA2787128A1 Antibody formulation and therapeutic regimens |
| 07/21/2011 | CA2786745A1 Wnt-binding agents and uses thereof |
| 07/21/2011 | CA2786660A1 Liver targeting molecules |
| 07/21/2011 | CA2786276A1 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof |
| 07/21/2011 | CA2785931A1 Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene |
| 07/20/2011 | EP2345722A1 Mutations in the parkin gene, compositions, methods and uses |
| 07/20/2011 | EP2345721A1 Recombinant gelatin in vaccines |
| 07/20/2011 | EP2345673A1 Humanized anti-granulocyte MN-3 antibody and uses thereof |
| 07/20/2011 | EP2345672A1 Anti-glycated cd59 antibodies and uses thereof |
| 07/20/2011 | EP2345671A1 Optimized fc variants and methods for their generation |
| 07/20/2011 | EP2345670A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 07/20/2011 | EP2345425A2 Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IgGs |
| 07/20/2011 | EP2345424A1 CD4-specific antibody TRX1 and uses therefor |
| 07/20/2011 | EP2344686A1 Novel triple tag sequences and methods of use thereof |
| 07/20/2011 | EP2344648A2 Recombinant vectors |
| 07/20/2011 | EP2344546A1 Single chain fc type iii interferons and methods of using same |
| 07/20/2011 | EP2344545A1 Amyloid-beta peptide crystal structure |
| 07/20/2011 | EP2344544A2 Novel antibodies recognizing native annexin a3 |
| 07/20/2011 | EP2344543A2 Treatment method |
| 07/20/2011 | EP2344542A2 Tubercolosis vaccines targeted to cd40 |
| 07/20/2011 | EP2344541A2 Antibodies directed to cd105 and uses thereof |
| 07/20/2011 | EP2344540A2 Cd86 antagonist multi-target binding proteins |
| 07/20/2011 | EP2344539A1 Treatment of pediatric acute lymphoblastic leukemia |
| 07/20/2011 | EP2344538A2 Antibodies against il-25 |
| 07/20/2011 | EP2344537A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 07/20/2011 | EP2344536A1 Antibodies directed to dll4 and uses thereof |
| 07/20/2011 | EP2344535A1 Antibodies against sonic hedgehog homolog and uses thereof |
| 07/20/2011 | EP2344534A1 New hcv entry factor, occludin |